[CLDX] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 86.11%
YoY- 42.56%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 3,480 236 715 2,763 3,829 1,389 2,178 8.11%
PBT -13,373 -11,259 -11,779 -16,407 -28,566 -31,952 -32,359 -13.68%
Tax 382 -228 -2,990 -15,798 1,276 -828 -782 -
NP -13,373 -11,031 -11,779 -16,407 -28,566 -31,952 -32,359 -13.68%
Tax Rate - - - - - - - -
Total Cost 16,853 11,267 12,494 19,170 32,395 33,341 34,537 -11.26%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -384.28 -4,674.15 -1,647.41 -593.81 -746.04 -2,300.36 -1,485.72 -20.16%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.34 -0.50 -0.84 -1.67 -3.42 -4.85 -4.93 -35.93%
EPS Diluted -0.34 -0.50 -0.84 -1.67 -3.42 -4.85 -4.93 -35.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.